Today: 21 May 2026
Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

LOS ANGELES, January 20, 2026, 05:32 (PST)

  • Netflix revised its Warner Bros. Discovery agreement, now proposing a $27.75-per-share all-cash offer while maintaining the enterprise value at $82.7 billion.
  • Paramount Skydance’s $30-per-share tender offer is set to expire on Jan. 21.
  • Warner Bros. Discovery revealed a per-share valuation range of $1.33 to $6.86 for the upcoming Discovery Global spinoff.

Netflix has shifted to an all-cash bid for Warner Bros. Discovery’s studio and streaming units, keeping the price steady at $82.7 billion in a move to edge out Paramount Skydance. The updated offer would pay Warner shareholders $27.75 per share, according to a filing on Tuesday.

The move comes just a day ahead of Paramount’s tender offer deadline on Jan. 21, following a drop in Netflix shares that made the stock portion less attractive. Netflix announced it plans to back the revised offer using cash reserves, credit lines, and committed financing.

Warner’s board had initially approved Netflix’s original offer of $23.25 in cash plus $4.50 in Netflix stock. Now, the revised deal drops the stock component but keeps the total price unchanged. The package covers Warner’s film and TV studios, its extensive content library, and the HBO Max streaming service, known for hits like “Game of Thrones,” “Harry Potter,” and DC’s Batman and Superman. The Business Times

Warner’s plan to split its business remains on track: the streaming and studios unit will form a new company called Warner Bros, while the global linear networks—traditional cable channels—and other assets will be spun off into Discovery Global. Warner shareholders are set to receive shares in Discovery Global once the split happens, although the exact distribution ratio hasn’t been finalized.

Netflix co-CEO Ted Sarandos described the all-cash deal as a move to “provide greater financial certainty” and quicken the timeline to a shareholder vote. Warner expects that vote to take place by April, pending the U.S. Securities and Exchange Commission’s approval of the proxy materials. Netflix

Paramount insists the Discovery Global spinoff offers minimal value, warning investors its equity might range from worthless to just 50 cents a share. Warner, on the other hand, valued Discovery Global’s equity between $1.33 and $6.86 per share in a recent filing, with the higher figure linked to a potential acquisition.

Investors reacted cautiously to the announcement. Netflix shares edged up roughly 1.3% in premarket trading, while Warner Bros. Discovery dipped a bit, following the companies’ confirmation that the per-share price remained unchanged.

Paramount has escalated the battle to both the courtroom and the boardroom, suing Warner earlier this month to demand more transparency on the Netflix deal’s valuation. It also announced plans to nominate directors in a proxy fight. “Raise the bid. Money talks,” said Craig Huber, an analyst at Huber Research Partners. Reuters

Warner contends that Netflix’s offer poses less financial risk than Paramount’s, despite both deals saddling the merged company with heavy debt. The Netflix arrangement would leave around $85 billion in debt and a leverage ratio—debt to earnings—below four, compared to roughly seven under Paramount’s proposal. Warner also highlighted that Netflix’s investment-grade rating contrasts with Paramount’s junk status from S&P.

Last week, a Delaware judge turned down Paramount’s bid to fast-track its lawsuit, ruling the company hadn’t proven it faced “irreparable harm” from Warner’s disclosures. The judge noted that if Paramount’s tender offer fails, it could actually clear the way for the Netflix deal. Reuters

Cash isn’t the main hurdle—shareholder approval and regulatory scrutiny remain major wild cards. Lawmakers from both parties have flagged concerns over consolidation, and President Donald Trump has indicated he intends to get involved. Ross Benes, an Emarketer analyst, noted that Warner “does not want to sell to Paramount.” Reuters

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals
Previous Story

UPL share price slips as Advanta IPO papers hit SEBI: what the filing reveals

Nvidia stock price slips as China H200 talks drag; NVDA earnings date looms
Next Story

Nvidia stock price slips as China H200 talks drag; NVDA earnings date looms

Go toTop